新生學校財團法人新生醫護管理專科學校圖書館 |

Hypertension = a companion to Braunwald's heart disease /

紀錄類型:	書目-電子資源 : 單行本
正題名/作者:	Hypertension/ Henry R. Black and William J. Elliott.
其他題名:	a companion to Braunwald's heart disease /
作者:	Black, Henry R.
其他作者:	Elliott, William J.,
出版者:	Philadelphia :Elsevier Saunders, : c2007.,
面頁冊數:	xxii, 615 p. :ill. ; : 29 cm.;
附註:	Companion v. to: Braunwald's heart disease / [edited by] Douglas P. Zipes ... [et al.]. 7th ed. c2005.
標題:	Hypertension. -
電子資源:	An electronic book accessible through the World Wide Web; click for information
ISBN:	9781416030539

Hypertension = a companion to Braunwald's heart disease /
Black, Henry R.1942-

Hypertensiona companion to Braunwald's heart disease /[electronic resource] :Henry R. Black and William J. Elliott. - Philadelphia :Elsevier Saunders,c2007. - xxii, 615 p. :ill. ;29 cm.

Companion v. to: Braunwald's heart disease / [edited by] Douglas P. Zipes ... [et al.]. 7th ed. c2005.

Includes bibliographical references and index.

Section 1: Epidemiology & Pathophysiology -- 1. Epidemiology -- 2. Genetics of Hypertension -- 3. Pathogenesis of Hypertension -- -- Section 2: Diagnosis -- 4. Definition of Hypertension -- 5. Measurement of Blood -- 6. Home BP Measurements -- 7. ABPM -- 8. Secondary Hypertension: Renovascular Hypertension -- 9. Secondary Hypertension: Mineralocorticoid Excess States -- 10. Secondary Hypertension: Pheochromocytoma -- 11. Secondary Hypertension: Sleep Apnea -- 12. Rare Unusual Diagnoses -- -- Section 3: Risk Stratification -- 13. Natural History of (Untreated) Hypertension -- 14. The Special Problem of (Isolated) Systolic Hypertension -- 15. Assessment of Target Organ Damage -- 16. Prediction of Global Cardiovascular Risk -- -- Section 4: Treatment -- 17. Lifestyle Modifications -- 18. Diuretics -- 19. Beta-blockers -- 20. ACE-inhibitors and Angiotensin II Receptor Blockers -- 21. Calcium Antagonists -- 22. Alpha-Blockers -- 23. Other (Newer) Drugs, including centrally-acting drugs, aldosterone antagonists, vasopeptidase inhibitors, and endothelin antagonists -- -- Section 5: Outcome Studies -- 24. Design of Outcomes Studies -- 25. Meta-analyses -- -- Section 6: Hypertension and Concomitant Diseases -- 26. Ischemic Heart Disease -- 27. Heart Failure -- 28. Kidney Disease -- 29. Transplant Hypertension -- 30. Obesity -- 31. Peripheral Vascular Disease -- 32. Cerebrovascular Disease -- 33. Diabetes -- 34. Dyslipidemia -- -- Section 7: Special Populations & Special Situations -- -- 35. Pregnancy-Related Hypertension -- 36. Children and Adolescents -- 37. Elderly -- 38. Blacks -- 39. Hispanics -- 40. East Asians -- 41. South Asians -- 42. Refractory Hypertension -- 43. Peri-operative Hypertension -- 44. Emergencies and Urgencies -- -- Section 8: Hypertension Treatment in the Future -- 45. Hypertension Disease Management Service -- 46. Hypertension Genomics -- 47. Approval Process for Antihypertensive Drugs b7 sUS and International -- -- Section 9: Guidelines -- 48. US and Canadian Guidelines -- 49. European Guidelines, including BHS and ESH/ESC.

Clinical hypertension is one of the most serious long-term problems associated with heart disease. This companion to Braunwald's Heart Disease focuses in depth on this key area of cardiovascular medicine. Complete with practical clinical tools for management, it helps you manage the chronic problems of your hypertensive patients. It covers everything from epidemiology and pathophysiology through diagnosis, risk stratification, treatment, outcome studies, concomitant diseases, special populations and special situations, and future treatments. Addresses management of all special populations with chronic hypertensive disease.Includes Clinical Pearls for reducing complications of hypertension.Discusses hypertension and concomitant disease. Provides information on the practical management of hypertension and its role in complex diseases Emphasizes prevention of hypertensive diseases. Covers behavior management as an integral part of treatment plan for hypertensives and pre-hypertensives. Assesses drugs and other forms of treatment.Presents current clinical guidelines for the U.S., Canada, and Europe.Encourages aggressive patient management to ensure minimal risk of further cardiovascular problems.

Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2009.

Mode of access: World Wide Web.

ISBN: 9781416030539

Source: 109268:109314Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

72074
Hypertension.
Index Terms--Genre/Form:

96803
Electronic books.

LC Class. No.: RC685.H8 / B58 2007

Dewey Class. No.: 616.1/2

National Library of Medicine Call No.: 2007 A-021

Hypertension = a companion to Braunwald's heart disease /
LDR:07091cmm 2200361Ia 4500 001 165780
003 OCoLC
005 20110615082806.0
006 m d
007 cr cn|||||||||
008 160223s2007 paua ob 001 0 eng d
020 $a 9781416030539
020 $a 1416030530
035 $a (OCoLC)489073587
035 $a ocn489073587
037 $a 109268:109314 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $b eng $c OPELS
049 $a TEFA
050 1 4 $a RC685.H8 $b B58 2007
060 1 4 $a 2007 A-021
060 1 4 $a WG 340 $b H9942595 2007
082 0 4 $a 616.1/2 $2 22
100 1 $a Black, Henry R. $q (Henry Richard), $d 1942- $3 230347
245 1 0 $a Hypertension $h [electronic resource] : $b a companion to Braunwald's heart disease / $c Henry R. Black and William J. Elliott.
260 $a Philadelphia : $c c2007. $b Elsevier Saunders,
300 $a xxii, 615 p. : $b ill. ; $c 29 cm.
500 $a Companion v. to: Braunwald's heart disease / [edited by] Douglas P. Zipes ... [et al.]. 7th ed. c2005.
504 $a Includes bibliographical references and index.
505 0 $a Section 1: Epidemiology & Pathophysiology -- 1. Epidemiology -- 2. Genetics of Hypertension -- 3. Pathogenesis of Hypertension -- -- Section 2: Diagnosis -- 4. Definition of Hypertension -- 5. Measurement of Blood -- 6. Home BP Measurements -- 7. ABPM -- 8. Secondary Hypertension: Renovascular Hypertension -- 9. Secondary Hypertension: Mineralocorticoid Excess States -- 10. Secondary Hypertension: Pheochromocytoma -- 11. Secondary Hypertension: Sleep Apnea -- 12. Rare Unusual Diagnoses -- -- Section 3: Risk Stratification -- 13. Natural History of (Untreated) Hypertension -- 14. The Special Problem of (Isolated) Systolic Hypertension -- 15. Assessment of Target Organ Damage -- 16. Prediction of Global Cardiovascular Risk -- -- Section 4: Treatment -- 17. Lifestyle Modifications -- 18. Diuretics -- 19. Beta-blockers -- 20. ACE-inhibitors and Angiotensin II Receptor Blockers -- 21. Calcium Antagonists -- 22. Alpha-Blockers -- 23. Other (Newer) Drugs, including centrally-acting drugs, aldosterone antagonists, vasopeptidase inhibitors, and endothelin antagonists -- -- Section 5: Outcome Studies -- 24. Design of Outcomes Studies -- 25. Meta-analyses -- -- Section 6: Hypertension and Concomitant Diseases -- 26. Ischemic Heart Disease -- 27. Heart Failure -- 28. Kidney Disease -- 29. Transplant Hypertension -- 30. Obesity -- 31. Peripheral Vascular Disease -- 32. Cerebrovascular Disease -- 33. Diabetes -- 34. Dyslipidemia -- -- Section 7: Special Populations & Special Situations -- -- 35. Pregnancy-Related Hypertension -- 36. Children and Adolescents -- 37. Elderly -- 38. Blacks -- 39. Hispanics -- 40. East Asians -- 41. South Asians -- 42. Refractory Hypertension -- 43. Peri-operative Hypertension -- 44. Emergencies and Urgencies -- -- Section 8: Hypertension Treatment in the Future -- 45. Hypertension Disease Management Service -- 46. Hypertension Genomics -- 47. Approval Process for Antihypertensive Drugs b7 sUS and International -- -- Section 9: Guidelines -- 48. US and Canadian Guidelines -- 49. European Guidelines, including BHS and ESH/ESC.
505 0 0 $g 1. $t Epidemiology of hypertension -- $g 2. $t Genetics of hypertension -- $g 3. $t Pathophysiology of hypertension -- $g 4. $t Defining hypertension -- $g 5. $t Office blood pressure measurement -- $g 6. $t Home monitoring of blood pressure -- $g 7. $t Ambulatory blood pressure monitoring in hypertension -- $g 8. $t Secondary hypertension: renovascular hypertension -- $g 9. $t Secondary hypertension: mineralcorticoid excess states -- $g 10. $t Secondary hypertension: pheochromocytoma -- $g 11. $t Secondary hypertension: sleep apnea -- $g 12. $t Rare and unusual forms of hypertension -- $g 13. $t The natural history of untreated hypertension -- $g 14. $t The special problem of isolated systolic hypertension -- $g 15. $t Assessment of hypertensive target organ damage -- $g 16. $t Prediction of global cardiovascular risk in hypertension -- $g 17. $t Diet and blood pressure -- $g 18. $t Diruretic therapy in cardiovascular disease -- $g 19. $t B-Blockers in hypertension -- $g 20. $t Angiotensin-converting enzyme inhibitors -- $g 21. $t Angiotensin receptor blockers -- $g 22. $t A-Blockers -- $g 24. $t New and investigational drugs for hypertension -- $g 25. $t Design of outcomes studies -- $g 26. $t Meta-analysis of hypertension trials -- $g 27. $t Ischemic heart disease in hypertension -- $g 28. $t Heart failure in hypertension -- $g 29. $t Kidney disease in hypertension -- $g 30. $t Transplant hypertension -- $g 31. $t Obesity in hypertension -- $g 32. $t Peripheral arterial disease in hypertension -- $g 33. $t Cerebrovascular disease in hypertension -- $g 34. $t Hypertension in diabetes mellitus -- $g 35. $t Dyslipidemia in hypertension -- $g 36. $t Hypertension in pregnancy -- $g 37. $t Hypertension in children and adolescents -- $g 38. $t Hypertension in the elderly -- $g 39. $t Hypertension in African Americans -- $g 40. $t Hypertension in Hispanics -- $g 41. $t Hypertension in East Asians and Pacific Islanders -- $g 42. $t Hypertension in South Asians -- $g 43. $t Resistant hypertension -- $g 44. $t Hypertension and the perioperative period -- $g 45. $t Hypertensive emergencies and urgencies -- $g 46. $t Hypertension disease management services -- $g 47. $t Antihypertensive drug development: a regulatory perspective -- $g 48. $t U.S. and Canadian guidelines for hypertension -- $g 49. $t European, American, and British guidelines: similarities and differences.
520 $a Clinical hypertension is one of the most serious long-term problems associated with heart disease. This companion to Braunwald's Heart Disease focuses in depth on this key area of cardiovascular medicine. Complete with practical clinical tools for management, it helps you manage the chronic problems of your hypertensive patients. It covers everything from epidemiology and pathophysiology through diagnosis, risk stratification, treatment, outcome studies, concomitant diseases, special populations and special situations, and future treatments. Addresses management of all special populations with chronic hypertensive disease.Includes Clinical Pearls for reducing complications of hypertension.Discusses hypertension and concomitant disease. Provides information on the practical management of hypertension and its role in complex diseases Emphasizes prevention of hypertensive diseases. Covers behavior management as an integral part of treatment plan for hypertensives and pre-hypertensives. Assesses drugs and other forms of treatment.Presents current clinical guidelines for the U.S., Canada, and Europe.Encourages aggressive patient management to ensure minimal risk of further cardiovascular problems.
533 $a Electronic reproduction. $b Amsterdam : $c Elsevier Science & Technology, $d 2009. $n Mode of access: World Wide Web. $n System requirements: Web browser. $n Title from title screen (viewed on Dec. 9, 2009). $n Access may be restricted to users at subscribing institutions.
650 0 $a Hypertension. $3 72074
650 0 $a Heart $x Diseases. $3 71513
650 6 $a Hypertension art�erielle. $3 321220
650 6 $a C�ur $x Maladies. $3 321608
655 7 $a Electronic books. $2 local. $3 96803
700 1 $a Elliott, William J., $c M.D. $3 230348
710 2 $a ScienceDirect (Online service) $3 254709
730 0 $a Braunwald's heart disease. $3 229166
776 1 $c Original $z 1416030530 $z 9781416030539 $w (DLC) 2006045231 $w (OCoLC)68705605
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9781416030539 $z An electronic book accessible through the World Wide Web; click for information
994 $a C0 $b TEF